EUCTR2004-003000-37-IT进行中（未招募）不适用
A Double-Blind, Multicenter Study to Assess the LDL-C Lowering of Combination tablets Ezetimibe/Simvastatin 10mg/20mg and Ezetimibe/Simvastatin 10mg/40mg compared to Atorvastatin 20mg in Patients with Type II Diabetes.
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
A Double-Blind, Multicenter Study to Assess the LDL-C Lowering of Combination tablets Ezetimibe/Simvastatin (10mg/20mg) and Ezetimibe/Simvastatin (10mg/40mg) compared to Atorvastatin 20mg in Patients with Type II Diabetes. - Eze/Simva Switch Study in DiabeticsHypercholesterolemia in patients with Type II DiabetesMedDRA version: 7.0Level: LLTClassification code 10020603EUCTR2004-003000-37-DEMerck & Co. Inc.
进行中（未招募）
1 期
A Double-Blind, Multicenter Study to Assess the LDL-C Lowering of Combination tablets Ezetimibe/Simvastatin (10mg/20mg) and Ezetimibe/Simvastatin (10mg/40mg) compared to Atorvastatin 20mg in Patients with Type II Diabetes. - Eze/Simva Switch Study in DiabeticsEUCTR2004-003000-37-LTMerck & Co., Inc.500
进行中（未招募）
1 期
A Double-Blind, Multicenter Study to Assess the LDL-C Lowering of Combination tablets Ezetimibe/Simvastatin (10mg/20mg) and Ezetimibe/Simvastatin (10mg/40mg) compared to Atorvastatin 20mg in Patients with Type II Diabetes. - Eze/Simva Switch Study in DiabeticsHypercholesterolemia in patients with Type II DiabetesMedDRA version: 7.0 Level: LLT Classification code 10020603EUCTR2004-003000-37-BEMerck Sharp & Dohme BV500
进行中（未招募）
1 期
A Double-Blind, Multicenter Study to Assess the LDL-C Lowering of Combination tablets Ezetimibe/Simvastatin (10mg/20mg) and Ezetimibe/Simvastatin (10mg/40mg) compared to Atorvastatin 20mg in Patients with Type II Diabetes. - Eze/Simva Switch Study in DiabeticsHypercholesterolemia in patients with Type II DiabetesMedDRA version: 7.0 Level: LLT Classification code 10020603EUCTR2004-003000-37-ESMerck & Co. Inc.250
进行中（未招募）
不适用
A Multicenter, Double-Blind Study to Evaluate the Safety, Efficacy and Pharmacokinetics of the Human Anti-TNF Monoclonal Antibody Adalimumab in Pediatric Subjects with Moderate to Severe Crohn's DiseaseEUCTR2006-004814-41-NLAbbott GmbH & Co. KG184